This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/russia/530372-astrazeneca-sputnik-v-mix-trial/
The article has changed 3 times. There is an RSS feed of changes available.
Version 0 | Version 1 |
---|---|
Russia approves clinical trials of Covid-19 vaccine cocktail: 150 volunteers to receive one dose each of Sputnik V & AstraZeneca | Russia approves clinical trials of Covid-19 vaccine cocktail: 150 volunteers to receive one dose each of Sputnik V & AstraZeneca |
(about 1 month later) | |
The Russian Ministry of Health is to test the effectiveness of combining the Russian Sputnik V Covid-19 vaccine with the British AstraZeneca jab. Clinical trials are due to begin soon and are planned to last until March 2022. | The Russian Ministry of Health is to test the effectiveness of combining the Russian Sputnik V Covid-19 vaccine with the British AstraZeneca jab. Clinical trials are due to begin soon and are planned to last until March 2022. |
It is planned to check the “safety and immunogenicity study of the drug combination.” The process will be conducted by five different medical organizations around the country. | It is planned to check the “safety and immunogenicity study of the drug combination.” The process will be conducted by five different medical organizations around the country. |
The idea of combining the two vaccines was first discussed last year, but in May 2021, the Health Ministry’s ethical committee opted to postpone the approval of the clinical trials until later. Now, they have been given the green light, and 150 volunteers will take part. | The idea of combining the two vaccines was first discussed last year, but in May 2021, the Health Ministry’s ethical committee opted to postpone the approval of the clinical trials until later. Now, they have been given the green light, and 150 volunteers will take part. |
Both the Sputnik V and AstraZeneca vaccines are two-component adenovirus vector vaccines. In the British shot, both the first and second components use the same vector, while Sputnik V has two completely different jabs. The combination will involve the first dose of the Russian formula, which is based on the same vector used by AstraZeneca. | Both the Sputnik V and AstraZeneca vaccines are two-component adenovirus vector vaccines. In the British shot, both the first and second components use the same vector, while Sputnik V has two completely different jabs. The combination will involve the first dose of the Russian formula, which is based on the same vector used by AstraZeneca. |
The initial dose of Sputnik V is also being given to Russians as a stand-alone vaccine, dubbed ‘Sputnik Light’. | The initial dose of Sputnik V is also being given to Russians as a stand-alone vaccine, dubbed ‘Sputnik Light’. |
The plans to test the combination of the two jabs were announced last year by AstraZeneca, which revealed that it would “soon begin exploring with Gamaleya Research Institute in Russia to understand whether two adenovirus-based vaccines can be successfully combined.” | The plans to test the combination of the two jabs were announced last year by AstraZeneca, which revealed that it would “soon begin exploring with Gamaleya Research Institute in Russia to understand whether two adenovirus-based vaccines can be successfully combined.” |
The Russian Direct Investment Fund, the entity responsible for marketing Sputnik V abroad, welcomed the news, noted that trials of vaccine cocktails have been ongoing in the UAE, Azerbaijan, and Argentina since February. | The Russian Direct Investment Fund, the entity responsible for marketing Sputnik V abroad, welcomed the news, noted that trials of vaccine cocktails have been ongoing in the UAE, Azerbaijan, and Argentina since February. |
Sputnik V was the first Covid-19 vaccine to be registered in the world, in August 2020. Since then, it has been approved in 69 countries. Earlier this month, British magazine Nature published an article on the shot’s usage outside of Russia, concluding that evidence shows it is safe and effective. | Sputnik V was the first Covid-19 vaccine to be registered in the world, in August 2020. Since then, it has been approved in 69 countries. Earlier this month, British magazine Nature published an article on the shot’s usage outside of Russia, concluding that evidence shows it is safe and effective. |
Like this story? Share it with a friend! | Like this story? Share it with a friend! |
Dear readers and commenters, | |
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
Sorry for the inconvenience, and looking forward to your future comments, | |
RT Team. |